GCLLX Performance — Goldman Sachs Enhanced U.S. Equity Fund, Class C
Data updated: 2025-11-13
GCLLX returned +11.97% over one year to Aug 2025. Annualised returns are +17.57% over 3 years and +13.04% over 5 years. Against its US Large Blend category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $163, against $154 for the category, and to $112 over one year, against $112. Volatility over the past three years was 14.94% a year. In the 12 months to Aug 2025 the fund took in a net $61.0M, and assets reached $455.13M.
GCLLX Growth of $100
What $100 invested in Goldman Sachs Enhanced U.S. Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | GCLLX | Category average |
|---|---|---|
| 1 year (Sep 2024 – Aug 2025) | $112 | $112 |
| 3 years (Sep 2022 – Aug 2025) | $163 | $154 |
| 5 years (Sep 2020 – Aug 2025) | $185 | $174 |
| Since data start (Sep 2019 – Aug 2025) | $224 | $202 |
GCLLX Trailing Returns
Total returns to Aug 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +11.97% |
| 3 years (annualised) | +17.57% |
| 5 years (annualised) | +13.04% |
GCLLX Annual Returns
Calendar-year total returns of Goldman Sachs Enhanced U.S. Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Aug) | +7.08% |
| 2024 | +21.65% |
| 2023 | +26.92% |
| 2022 | −17.88% |
| 2021 | +25.44% |
| 2020 | +20.25% |
| 2019 (Sep–Dec) | +9.28% |
GCLLX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +2.5% | −2.2% | −6.0% | −0.7% | +5.7% | +4.4% | +1.9% | +1.8% | — | — | — | — |
| 2024 | +1.3% | +4.8% | +3.7% | −4.5% | +4.1% | +2.6% | +1.4% | +2.1% | +2.0% | −1.1% | +6.3% | −2.4% |
| 2023 | +7.3% | −2.5% | +2.6% | +1.6% | +0.3% | +6.7% | +3.3% | −1.4% | −4.5% | −2.4% | +9.0% | +5.0% |
| 2022 | −5.7% | −2.8% | +3.1% | −8.3% | −0.6% | −8.2% | +9.6% | −3.5% | −9.0% | +8.5% | +5.8% | −5.9% |
| 2021 | −1.4% | +2.3% | +3.7% | +5.6% | +0.3% | +1.8% | +2.6% | +3.0% | −4.2% | +6.6% | −1.5% | +4.7% |
| 2020 | +0.2% | −8.1% | −12.1% | +13.1% | +5.0% | +2.1% | +5.8% | +6.8% | −3.8% | −2.0% | +10.4% | +4.2% |
| 2019 | — | — | — | — | — | — | — | — | +1.4% | +1.4% | +3.2% | +3.0% |
GCLLX Risk
Risk measures from monthly returns over Sep 2022 – Aug 2025.
- 3-year volatility (annualised): 14.94%
- 3-year Sharpe ratio: 0.88 (vs 4.5% risk-free rate)
- Best month: +8.96% (Nov 2023)
- Worst month: −8.99% (Sep 2022)
GCLLX Fund Flows
Monthly money in and out of Goldman Sachs Enhanced U.S. Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $61.0M
- 12-month gross sales (incl. reinvestments): $164.0M
- Sales ÷ redemptions: 1.59×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Aug 2025 | $1.8M | $9.1M | −$7.3M |
| Jul 2025 | $7.5M | $13.5M | −$6.0M |
| Jun 2025 | $3.4M | $5.0M | −$1.6M |
| May 2025 | $4.6M | $16.5M | −$11.8M |
| Apr 2025 | $29.2M | $7.0M | $22.2M |
| Mar 2025 | $5.1M | $7.3M | −$2.2M |
| Feb 2025 | $8.0M | $8.7M | −$646K |
| Jan 2025 | $9.7M | $11.3M | −$1.6M |
| Dec 2024 | $17.2M | $6.9M | $10.3M |
| Nov 2024 | $9.5M | $6.1M | $3.4M |
| Oct 2024 | $14.3M | $6.1M | $8.2M |
| Sep 2024 | $53.7M | $5.6M | $48.2M |
GCLLX Assets Under Management
Net assets of Goldman Sachs Enhanced U.S. Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-08-31 | $455.13M |
| 2025-05-31 | $433.84M |
| 2025-02-28 | $422.64M |
| 2024-11-30 | $432.78M |
| 2024-08-31 | $343.90M |
| 2024-05-31 | $328.78M |
| 2024-02-29 | $148.39M |
| 2023-11-30 | $92.24M |
| 2023-08-31 | $70.65M |
| 2023-05-31 | $51.56M |
| 2023-02-28 | $42.39M |
| 2022-11-30 | $45.80M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.